Dr. Daniel Pollyea, MD
Claim this profileUniverstiy of Colorado Hospital
Studies Acute Myeloid Leukemia
Studies Myeloid Leukemia
7 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Daniel Pollyea, MD is currently running
KPT-9274
for Acute Myeloid Leukemia
This study will evaluate the safety and tolerability of oral KPT-9274 for the treatment of patients with relapsed or refractory acute myeloid leukemia.
Recruiting1 award Phase 1
Venetoclax, Azacitidine, and Cusatuzumab
for Acute Myeloid Leukemia
The goal of this clinical trial is to learn if participants treated with the experimental drug cusatuzumab added to venetoclax and azacitidine works to treat acute myeloid leukemia (AML) compared to venetoclax and azacitidine. Venetoclax and azacitidine are drugs commonly used to treat AML in patients that are unable to receive chemotherapy to treat AML. The main question the clinical trial aims to answer is does cusatuzumab added to venetoclax and azacitidine prolong the length of time participants live compared to venetoclax and azacitidine?
Recruiting1 award Phase 21 criteria
More about Daniel Pollyea, MD
Clinical Trial Related6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Daniel Pollyea, MD has experience with
- Azacitidine
- Venetoclax
- Omacetaxine
- CC-486
- KPT-9274
- ASTX727 LD
Breakdown of trials Daniel Pollyea, MD has run
Acute Myeloid Leukemia
Myeloid Leukemia
T-Lymphoblastic Leukemia/Lymphoma
Myelodysplastic syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Pollyea, MD specialize in?
Daniel Pollyea, MD focuses on Acute Myeloid Leukemia and Myeloid Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved treating patients, or patients who are undergoing treatment.
Is Daniel Pollyea, MD currently recruiting for clinical trials?
Yes, Daniel Pollyea, MD is currently recruiting for 3 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Daniel Pollyea, MD has studied deeply?
Yes, Daniel Pollyea, MD has studied treatments such as Azacitidine, Venetoclax, Omacetaxine.
What is the best way to schedule an appointment with Daniel Pollyea, MD?
Apply for one of the trials that Daniel Pollyea, MD is conducting.
What is the office address of Daniel Pollyea, MD?
The office of Daniel Pollyea, MD is located at: Universtiy of Colorado Hospital, Aurora, Colorado 80045 United States. This is the address for their practice at the Universtiy of Colorado Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.